Literature DB >> 11454791

Keratinocyte growth factor and coeliac disease.

V M Salvati1, M Bajaj-Elliott, R Poulsom, G Mazzarella, K E Lundin, E M Nilsen, R Troncone, T T MacDonald.   

Abstract

BACKGROUND: Coeliac disease is characterised by increased epithelial renewal associated with a mucosal T cell response to gliadin. Keratinocyte growth factor (KGF) is produced by cytokine activated gut stromal cells and may be a link between mucosal T cell activation in untreated coeliac disease and epithelial hyperplasia. AIMS: To characterise expression of KGF in coeliac disease.
METHODS: KGF transcripts in coeliac disease were measured by quantitative competitive reverse transcription-polymerase chain reaction (RT-PCR) and localised using in situ hybridisation. KGF production by gluten reactive CD4+ T cell clones was examined. In addition, KGF transcripts were measured following ex vivo challenge of coeliac biopsies with a peptic-tryptic digest of gliadin.
RESULTS: KGF transcripts were elevated in coeliac biopsies compared with normal controls but were not different from non-coeliac disease controls. By in situ hybridisation, KGF mRNA containing cells were present in the upper half of the lamina propria, most abundantly just under the epithelium. There was no signal from cells within the epithelium. Gluten reactive T cell clones did not make KGF. In vitro challenge of coeliac biopsies generated a strong interferon gamma response but a specific KGF response could not be detected because of an extremely high number of KGF transcripts in all cultured biopsies.
CONCLUSIONS: KGF is overexpressed in coeliac biopsies and in tissues with non-coeliac enteropathy. No evidence was found for KGF production by intraepithelial lymphocytes or lamina propria T cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454791      PMCID: PMC1728384          DOI: 10.1136/gut.49.2.176

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

Review 1.  T cells orchestrate intestinal mucosal shape and integrity.

Authors:  T T MacDonald; M Bajaj-Elliott; S L Pender
Journal:  Immunol Today       Date:  1999-11

2.  Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease.

Authors:  S Daum; U Bauer; H D Foss; D Schuppan; H Stein; E O Riecken; R Ullrich
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

3.  Increased production of interleukin 1 beta and hepatocyte growth factor may contribute to foveolar hyperplasia in enlarged fold gastritis.

Authors:  Y Yasunaga; Y Shinomura; S Kanayama; Y Higashimoto; M Yabu; Y Miyazaki; S Kondo; Y Murayama; H Nishibayashi; S Kitamura; Y Matsuzawa
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

4.  A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.

Authors:  H C Jung; L Eckmann; S K Yang; A Panja; J Fierer; E Morzycka-Wroblewska; M F Kagnoff
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

5.  Modulation of epithelial cell growth by intraepithelial gamma delta T cells.

Authors:  R Boismenu; W L Havran
Journal:  Science       Date:  1994-11-18       Impact factor: 47.728

6.  Keratinocyte growth factor in inflammatory bowel disease. Increased mRNA transcripts in ulcerative colitis compared with Crohn's disease in biopsies and isolated mucosal myofibroblasts.

Authors:  M Bajaj-Elliott; E Breese; R Poulsom; P D Fairclough; T T MacDonald
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

7.  Keratinocyte growth factor is highly overexpressed in inflammatory bowel disease.

Authors:  M Brauchle; M Madlener; A D Wagner; K Angermeyer; U Lauer; P H Hofschneider; M Gregor; S Werner
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

8.  Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease.

Authors:  E M Nilsen; F L Jahnsen; K E Lundin; F E Johansen; O Fausa; L M Sollid; J Jahnsen; H Scott; P Brandtzaeg
Journal:  Gastroenterology       Date:  1998-09       Impact factor: 22.682

Review 9.  Growth factors and the gastrointestinal tract.

Authors:  M S Murphy
Journal:  Nutrition       Date:  1998-10       Impact factor: 4.008

10.  Interactions between stromal cell--derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia.

Authors:  M Bajaj-Elliott; R Poulsom; S L Pender; N C Wathen; T T MacDonald
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

View more
  12 in total

1.  Critical role for tumor necrosis factor alpha in controlling the number of lumenal pathogenic bacteria and immunopathology in infectious colitis.

Authors:  N S Gonçalves; M Ghaem-Maghami; G Monteleone; G Frankel; G Dougan; D J Lewis; C P Simmons; T T MacDonald
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

2.  Interleukin 18 maintains a long-standing inflammation in coeliac disease patients.

Authors:  A J León; J A Garrote; A Blanco-Quirós; C Calvo; L Fernández-Salazar; A Del Villar; A Barrera; E Arranz
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

Review 3.  Initiation and resolution of mucosal inflammation.

Authors:  Melanie A Sherman; Daniel Kalman
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 4.  Small bowel review: Diseases of the small intestine.

Authors:  Alan B R Thomson; Laurie Drozdowski; Claudiu Iordache; Ben K A Thomson; Severine Vermeire; M Tom Clandinin; Gary Wild
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.487

Review 5.  Breaking Down Barriers: How Understanding Celiac Disease Pathogenesis Informed the Development of Novel Treatments.

Authors:  Francesco Valitutti; Alessio Fasano
Journal:  Dig Dis Sci       Date:  2019-07       Impact factor: 3.487

Review 6.  The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop.

Authors:  D Pagliari; R Urgesi; S Frosali; M E Riccioni; E E Newton; R Landolfi; F Pandolfi; R Cianci
Journal:  J Immunol Res       Date:  2015-05-18       Impact factor: 4.818

7.  TFF3 interacts with LINGO2 to regulate EGFR activation for protection against colitis and gastrointestinal helminths.

Authors:  Nicole Maloney Belle; Yingbiao Ji; Karl Herbine; Yun Wei; JoonHyung Park; Kelly Zullo; Li-Yin Hung; Sriram Srivatsa; Tanner Young; Taylor Oniskey; Christopher Pastore; Wildaliz Nieves; Ma Somsouk; De'Broski R Herbert
Journal:  Nat Commun       Date:  2019-09-27       Impact factor: 14.919

Review 8.  Palifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models.

Authors:  Paul W Finch; Lawrence J Mark Cross; Daniel F McAuley; Catherine L Farrell
Journal:  J Cell Mol Med       Date:  2013-09       Impact factor: 5.310

Review 9.  Intestinal Anti-tissue Transglutaminase2 Autoantibodies: Pathogenic and Clinical Implications for Celiac Disease.

Authors:  Mariantonia Maglio; Riccardo Troncone
Journal:  Front Nutr       Date:  2020-05-29

10.  Comparison of cytokine and gene activities in tissue and blood samples of patients with celiac disease.

Authors:  Ensieh KhalKhal; Zahra Razzaghi; Hakimeh Zali; Ayad Bahadorimonfared; Majid Iranshahi; Mohammad Rostami-Nejad
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.